These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 9778755)

  • 1. Efficacy of zanamivir for chemoprophylaxis of nursing home influenza outbreaks.
    Schilling M; Povinelli L; Krause P; Gravenstein M; Ambrozaitis A; Jones HH; Drinka P; Shult P; Powers D; Gravenstein S
    Vaccine; 1998 Nov; 16(18):1771-4. PubMed ID: 9778755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled zanamivir versus rimantadine for the control of influenza in a highly vaccinated long-term care population.
    Gravenstein S; Drinka P; Osterweil D; Schilling M; Krause P; Elliott M; Shult P; Ambrozaitis A; Kandel R; Binder E; Hammond J; McElhaney J; Flack N; Daly J; Keene O
    J Am Med Dir Assoc; 2005; 6(6):359-66. PubMed ID: 16286056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zanamivir use during transmission of amantadine-resistant influenza A in a nursing home.
    Lee C; Loeb M; Phillips A; Nesbitt J; Smith K; Fearon M; McArthur MA; Mazzulli T; Li Y; McGeer A
    Infect Control Hosp Epidemiol; 2000 Nov; 21(11):700-4. PubMed ID: 11089653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of zanamivir for chemoprophylaxis of concomitant influenza A and B in a complex continuing care population.
    Hirji Z; O'Grady S; Bonham J; Mak M; Takata-Shewchuk J; Hawkins K; Gardam M; Law L; Mazzulli T; Conly J
    Infect Control Hosp Epidemiol; 2002 Oct; 23(10):604-8. PubMed ID: 12400891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing influenza: amantadine, rimantadine and beyond.
    Fleming DM
    Int J Clin Pract; 2001 Apr; 55(3):189-95. PubMed ID: 11351773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new antiviral agent for influenza--is there a clinical niche?
    Couch RB
    N Engl J Med; 1997 Sep; 337(13):927-8. PubMed ID: 9302309
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group.
    Hayden FG; Gubareva LV; Monto AS; Klein TC; Elliot MJ; Hammond JM; Sharp SJ; Ossi MJ;
    N Engl J Med; 2000 Nov; 343(18):1282-9. PubMed ID: 11058672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled zanamivir versus placebo for the prevention of influenza outbreaks in an unvaccinated long-term care population.
    Ambrozaitis A; Gravenstein S; van Essen GA; Rubinstein E; Balciuniene L; Stikleryte A; Crawford C; Elliott M; Shult P
    J Am Med Dir Assoc; 2005; 6(6):367-74. PubMed ID: 16286057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of zanamivir for chemoprophylaxis of concomitant influenza A and B in a complex continuing-care population.
    Hirji Z; O'Grady S; Bonham J; Mak M; Takata-Shewchuk J; Hawkins K; Gardam M; Law L; Mazzulli T; Conly J
    Can Commun Dis Rep; 2001 Feb; 27(3):21-4. PubMed ID: 11227819
    [No Abstract]   [Full Text] [Related]  

  • 10. Updated treatment for influenza A and B.
    Montalto NJ; Gum KD; Ashley JV
    Am Fam Physician; 2000 Dec; 62(11):2467-76. PubMed ID: 11130232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuraminidase inhibitors for preventing and treating influenza in children.
    Matheson NJ; Symmonds-Abrahams M; Sheikh A; Shepperd S; Harnden A
    Cochrane Database Syst Rev; 2003; (3):CD002744. PubMed ID: 12917931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zanamivir: from drug design to the clinic.
    Elliott M
    Philos Trans R Soc Lond B Biol Sci; 2001 Dec; 356(1416):1885-93. PubMed ID: 11779388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perspectives on antiviral use during pandemic influenza.
    Hayden FG
    Philos Trans R Soc Lond B Biol Sci; 2001 Dec; 356(1416):1877-84. PubMed ID: 11779387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuraminidase inhibitors for treatment of influenza A and B infections.
    MMWR Recomm Rep; 1999 Dec; 48(RR-14):1-9. PubMed ID: 10632443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zanamivir: a rational approach to influenza B.
    Penn CR; Osterhaus A
    Scand J Infect Dis; 2001; 33(1):33-40. PubMed ID: 11234975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial.
    Monto AS; Robinson DP; Herlocher ML; Hinson JM; Elliott MJ; Crisp A
    JAMA; 1999 Jul; 282(1):31-5. PubMed ID: 10404908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duration of antiviral prophylaxis during nursing home outbreaks of influenza A: a comparison of 2 protocols.
    Drinka PJ; Gravenstein S; Schilling M; Krause P; Miller BA; Shult P
    Arch Intern Med; 1998 Oct; 158(19):2155-9. PubMed ID: 9801184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zanamivir prophylaxis: an effective strategy for the prevention of influenza types A and B within households.
    Monto AS; Pichichero ME; Blanckenberg SJ; Ruuskanen O; Cooper C; Fleming DM; Kerr C
    J Infect Dis; 2002 Dec; 186(11):1582-8. PubMed ID: 12447733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influenza outbreaks in aged-care facilities: staff vaccination and the emerging use of antiviral therapy.
    Guy RJ; Di Natale R; Kelly HA; Lambert SB; Tobin S; Robinson PM; Tallis G; Hampson AW
    Med J Aust; 2004 Jun; 180(12):640-2. PubMed ID: 15200364
    [No Abstract]   [Full Text] [Related]  

  • 20. Neuraminidase inhibitors for influenza.
    Moscona A
    N Engl J Med; 2005 Sep; 353(13):1363-73. PubMed ID: 16192481
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.